Cleveland Va Medical Research And Education Foundation
- Assets
- $4.0m
- Revenue
- $4.4m
- Investments
- $0.0
- Employees
- 56
- Location
- Cleveland, OH
- Founding
- 05/1995
- Data as of
- 12/2023
- EIN
- 34-1710663
Organization Overview
Cleveland Va Medical Research And Education Foundation is located in Cleveland, OH. The organization was established in 1995. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2023, Cleveland VA Medical Research And Education Foundation employed 56 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cleveland VA Medical Research And Education Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Cleveland VA Medical Research And Education Foundation generated $4.4m in total revenue. This organization has experienced exceptional growth, as over the past 9 years, it has increased revenue by an average of 10.5% each year . All expenses for the organization totaled $4.8m during the year ending 12/2023. While expenses have increased by 15.5% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE PRIMARY TAX-EXEMPT PURPOSE OF THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION, A 501(C)(3) MEDICAL RESEARCH FOUNDATION ESTABLISHED IN ACCORDANCE WITH TITLE 38, SUBCHAPTER IV-RESEARCH AND EDUCATION CORPORATIONS, SECTIONS 7361-7368, IS TO SUPPORT BIOMEDICAL RESEARCH AT THE LOUIS STOKES CLEVELAND VA MEDICAL CENTER.
Describe the Organization's Program Activity:
Part 3 - Line 4a
DR. KATARINA GREER, DOD AWARD NONENDOSCOPIC SCREENING TO IMPACT ESOPHAGEAL CANCER IN VETERANS ESOPHAGEAL ADENOCARCINOMA (EAC) HAS INCREASED MORE THAN 6-FOLD IN THE PAST FOUR DECADES. THE INCORPORATION OF A NON-ENDOSCOPIC DETECTION METHOD IN PRIMARY CARE PRACTICE WILL INCREASE THE POSITIVE PREDICTIVE VALUE OF EGD AND INCREASE THE DETECTION OF BARRETT'S ESOPHAGUS (BE). THIS STUDY WILL AIM TO DETERMINE SENSITIVITY, SPECIFICITY, AND POSITIVE PREDICTIVE VALUE OF ESOCHECK SAMPLING DEVICE ESOGUARD (DNA MARKER PANEL LABORATORY DIAGNOSTIC TEST) PERFORMED IN ROUTINE PRACTICE FOR DETECTING BE IN AN AT-RISK POPULATION. THE SECOND AIM OF THE STUDY IS TO COMPARE THE YIELD OF DETECTED BE USING AN ESOCHECK/ESOGUARD STRATEGY VERSUS STANDARD EGD ALONE STRATEGY IN ROUTINE PRACTICE IN AT-RISK POPULATIONS AT THE CLEVELAND VA. THE EXPECTED OUTCOME OF THE PROPOSED WORK IS THE GATHERING OF DETAILED INFORMATION ABOUT THE TEST PERFORMANCE CHARACTERISTICS, I.E., SENSITIVITY, SPECIFICITY, POSITIVE AND NEGATIVE PREDICTIVE VALUE. SHOULD THE SCREENING TEST PERFORM WELL, ESOCHECK/ESOGUARD TEST WOULD BE PRODUCED ON A LARGER SCALE, ITS MOLECULAR DIAGNOSTICS PROCESS WOULD BE AUTOMATED, DRIVING COSTS OF THE SCREENING DEVICE DOWN. TEST INDICATION COULD BE EXPANDED TO ALL OBESE PATIENTS OLDER THAN 50 WITHOUT A HISTORY OF CHRONIC GERD, EXPLORING THE PREVALENCE OF BE/ECA IN ASYMPTOMATIC INDIVIDUALS.
OTHER RESEARCH AND SERVICE ACTIVITIES.
DR. ELIAS VEIZI, NIH SUBAWARD A SEQUENCED-STRATEGY FOR IMPROVING OUTCOMES IN PATIENTS WITH KNEE OSTEOARTHRITIS PAIN" SKOAP STUDY. SKOAP IS A NATIONAL STUDY FUNDED BY THE HELPING ADDICTION LONG-TERM INITIATIVE OR NIH HEAL INITIATIVE. THE PURPOSE OF THE SKOAP STUDY IS TO COMPARE DIFFERENT TREATMENT OPTIONS FOR PEOPLE LIVING WITH KNEE OSTEOARTHRITIS PAIN. THE GOAL IS TO REDUCE PAIN AND IMPROVE FUNCTION USING CONSERVATIVE TREATMENT AND IF NEEDED, NON-SURGICAL PROCEDURAL TREATMENTS. THERE IS AN URGENT PUBLIC HEALTH NEED TO FIND CLINICALLY PROVEN TREATMENTS TO IMPROVE QUALITY OF LIFE AND REDUCE RELIANCE ON OPIOIDS, FOR LONG-TERM PAIN MANAGEMENT FOR PATIENTS SUFFERING FROM KNEE OA. THIS EFFECTIVENESS TRIAL WILL COMPARE AVAILABLE TREATMENTS FOR PAIN REDUCTION AND FUNCTIONAL IMPROVEMENT IN PATIENTS WITH KNEE OSTEOARTHRITIS. THE RESULTS CAN LEAD TO IMPROVED PATIENT SELECTION AND INFORM EVIDENCE-BASED GUIDANCE BY OFFERING WELL-TESTED, EFFECTIVE, NON-OPIOID ALTERNATIVES.
DR. RON TRIOLO, PARALYZED VETERANS OF AMERICA AWARD, ADAPTED VIRTUAL REALITY GAMES TO IMPROVE ENGAGEMENT DURING STIMULATION- DRIVEN EXERCISE THE OVERALL GOAL OF THIS PROJECT IS TO DEVELOP EFFECTIVE IMMERSIVE VR GAMES TAILORED TO THE ABILITIES OF VETERANS WITH PARALYSIS TO IMPROVE STIMULATION-INDUCED EXERCISE EXPERIENCE AND PERFORMANCE. THIS WILL BE DIVIDED INTO TWO OBJECTIVES AND ANTICIPATED OUTCOMES: OBJECTIVE 1: DEVELOP IMMERSIVE VR GAMES THAT INCREASE USER ENGAGEMENT AND ACTIVE INPUT DURING STIMULATION-INDUCED CYCLING AND ROWING EXERCISES. OBJECTIVE 2: ASSESS THE EFFICACY OF THE DEVELOPED VR GAMES IN TERMS OF PHYSIOLOGICAL RESPONSE, FUNCTIONAL EXERCISE OUTPUT, AND PARTICIPANT RATINGS OF ENGAGEMENT
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Brigid Wilson PHD Hce | 40 | $127,386 | |
Jeff Moore PHD Executive Di | Officer | 40 | $126,437 |
Richard Dechant Trustee/dire | Trustee | 1 | $0 |
Jill K D Mellon JD MBA Fach President | OfficerTrustee | 1 | $0 |
George Jaskiw MD Secretary | OfficerTrustee | 1 | $0 |
Murray Altose MD Trustee/dire | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $51,324 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $51,324 |
| Total Program Service Revenue | $4,276,657 |
| Investment income | $62,904 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $4,390,885 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $126,437 |
| Compensation of current officers, directors, key employees. | $126,437 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $2,118,385 |
| Pension plan accruals and contributions | $60,922 |
| Other employee benefits | $284,104 |
| Payroll taxes | $181,161 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $2,025 |
| Fees for services: Accounting | $19,799 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $1,353,971 |
| Advertising and promotion | $0 |
| Office expenses | $10,682 |
| Information technology | $26,182 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $74,076 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $81,494 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $5,959 |
| All other expenses | $15,347 |
| Total functional expenses | $4,832,226 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $373,877 |
| Savings and temporary cash investments | $1,250,196 |
| Pledges and grants receivable | $2,369,212 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $3,283 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $3,996,568 |
| Accounts payable and accrued expenses | $672,089 |
| Grants payable | $0 |
| Deferred revenue | $89,482 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $761,571 |
| Net assets without donor restrictions | $3,234,997 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $3,996,568 |